Daraprim
NDC 69413-330, pyrimethamine, tablet, from Vyera Pharmaceuticals LLC.
- Product NDC
- 69413-330
- Status
- Listed
- Labeler
- Vyera Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA008578
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69413-330 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIMETHAMINE25 mg/1
Pharmacologic classes
Dihydrofolate Reductase Inhibitor Antimalarial [EPC]; Dihydrofolate Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69413-330-10 | 69413033010 | 100 TABLET in 1 BOTTLE, PLASTIC (69413-330-10) |
| 69413-330-30 | 69413033030 | 30 TABLET in 1 BOTTLE, PLASTIC (69413-330-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5368616d-6520-6f6e-2053-686b72656c69
Use it
Look up 69413-330 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69413-330 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69413-330. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.